Photo from wikipedia
Adding dexrazoxane to the treatment during neoadjuvant/adjuvant anthracycline‐based chemotherapy in patients with breast cancer prevents the development of heart failure. In this study, we investigated whether dexrazoxane has a protective… Click to show full abstract
Adding dexrazoxane to the treatment during neoadjuvant/adjuvant anthracycline‐based chemotherapy in patients with breast cancer prevents the development of heart failure. In this study, we investigated whether dexrazoxane has a protective effect on arrhythmia resulting from chemotherapy.
Keywords:
patients breast;
neoadjuvant adjuvant;
adjuvant anthracycline;
based chemotherapy;
anthracycline based;
dexrazoxane
Journal Title: International Journal of Clinical Practice
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Clinical Practice
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!